Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Blood|March 4, 2018
Optimizing therapy in advanced-stage Hodgkin lymphomaSean H Lim, Peter W M JohnsonHaematologica|September 24, 2009
Anti-CD20 monoclonal antibodies: historical and future perspectivesSean H Lim, Stephen A Beers, Ruth R French, et al.Hematology. American Society of Hematology. Education Program|December 4, 2016
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?Peter W M JohnsonHematology. American Society of Hematology. Education Program|December 10, 2013
Management of early-stage Hodgkin lymphoma: is there still a role for radiation?Peter W M JohnsonHematological Oncology|June 9, 2023
Are we reaching the maximum cure rate for Hodgkin lymphoma?Peter W M JohnsonJournal of Immunology (Baltimore, Md. : 1950)|August 3, 2014
Translational medicine in action: anti-CD20 therapy in lymphomaSean H Lim, Ronald LevyCurrent Oncology Reports|May 3, 2021
Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches-Focus on EZH2-Targeted DrugsJemma Longley, Peter W M JohnsonBritish Journal of Haematology|November 9, 2018
Current treatment paradigms for advanced stage Hodgkin lymphomaJemma Longley, Peter W M JohnsonHematological Oncology|June 9, 2021
Personalized medicine for Hodgkin lymphoma: Mitigating toxicity while preserving cureJemma Longley, Peter W M JohnsonChinese Clinical Oncology|April 6, 2015
Risk- and response-adapted strategies for the management of Hodgkin lymphomaMarcus Remer, Peter W M JohnsonPageof 11